CLBFX
Price
$37.18
Change
-$0.14 (-0.38%)
Updated
Aug 19 closing price
Net Assets
255.61B
FPUKX
Price
$26.08
Change
-$0.17 (-0.65%)
Updated
Aug 19 closing price
Net Assets
31.73B
Interact to see
Advertisement

CLBFX vs FPUKX

Header iconCLBFX vs FPUKX Comparison
Open Charts CLBFX vs FPUKXBanner chart's image
American Funds American Balanced 529F
Price$37.18
Change-$0.14 (-0.38%)
VolumeN/A
Net Assets255.61B
Fidelity Puritan K
Price$26.08
Change-$0.17 (-0.65%)
VolumeN/A
Net Assets31.73B
CLBFX vs FPUKX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CLBFX vs. FPUKX commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBFX is a Buy and FPUKX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBFX has more cash in the bank: 256B vs. FPUKX (31.7B). CLBFX pays higher dividends than FPUKX: CLBFX (1.97) vs FPUKX (1.62). CLBFX was incepted earlier than FPUKX: CLBFX (23 years) vs FPUKX (17 years). CLBFX (0.67) is less costly to investors than FPUKX (0.40). FPUKX is a more actively managed with annual turnover of: 55.00 vs. CLBFX (44.00). FPUKX has a lower initial minimum investment than CLBFX: FPUKX (0) vs CLBFX (250). CLBFX annual gain was more profitable for investors over the last year : 6.98 vs. FPUKX (1.48). CLBFX return over 5 years is better than : 40.55 vs. FPUKX (12.46).
CLBFXFPUKXCLBFX / FPUKX
Total Expense Ratio0.670.40168%
Annual Report Gross Expense Ratio0.670.40168%
Fund Existence23 years17 years-
Gain YTD9.4356.730140%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets256B31.7B808%
Annual Yield % from dividends1.971.62122%
Returns for 1 year6.981.48471%
Returns for 3 years32.2616.71193%
Returns for 5 years40.5512.46325%
Returns for 10 years88.4040.62218%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALGS8.820.05
+0.57%
Aligos Therapeutics Inc
SPOK17.960.01
+0.07%
Spok Holdings
CCIRU13.65N/A
N/A
Cohen Circle Acquisition Corp. I
VRNA105.56-0.23
-0.22%
Verona Pharma plc
DYN12.25-0.08
-0.65%
Dyne Therapeutics